Financial Review: iSpecimen (NASDAQ:ISPC) & NewGenIvf Group (NASDAQ:NIVF)

iSpecimen (NASDAQ:ISPC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends.

Institutional and Insider Ownership

13.6% of iSpecimen shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 12.2% of iSpecimen shares are held by insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares iSpecimen and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iSpecimen	-172.48%	-395.15%	-121.72%
NewGenIvf Group	N/A	N/A	N/A

Valuation & Earnings

This table compares iSpecimen and NewGenIvf Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$9.29 million	0.68	-$12.50 million	($9.51)	-0.12
NewGenIvf Group	$5.43 million	0.73	-$520,000.00	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than iSpecimen.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for iSpecimen and NewGenIvf Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1	0	0	0	1.00
NewGenIvf Group	1	0	0	0	1.00

Volatility & Risk

iSpecimen has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500.

Summary

NewGenIvf Group beats iSpecimen on 7 of the 9 factors compared between the two stocks.

About iSpecimen

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.